Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Chyawanprash for the prevention of COVID-19 infection among healthcare workers: A Randomized Controlled Trial

Arun Gupta, Amit Madan, Babita Yadav, Richa Singhal, View ORCID ProfilePallavi Suresh Mundada, Yogesh Kumar Pandey, Riju Agarwal, Rakesh Rana, Arunabh Tripathi, Bhagwan Sahay Sharma, BCS Rao, Bharti Gupta, Narayanam Srikanth, Kartar Singh Dhiman
doi: https://doi.org/10.1101/2021.02.17.21251899
Arun Gupta
1 Dept of Panchakarma, Ch. Brahmapraksh Ayurveda Charak Sansthan, Khera Dabar, Najafgarh, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arun24@hotmail.com
Amit Madan
2 Central Ayurveda Research Institute, CCRAS, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dr.madan.amit@gmail.com
Babita Yadav
3 Central Council for Research in Ayurvedic Sciences, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: drbabitayadav@gmail.com
Richa Singhal
3 Central Council for Research in Ayurvedic Sciences, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: richa.singhal2k@gmail.com
Pallavi Suresh Mundada
4 Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pallavi Suresh Mundada
  • For correspondence: vd.psm2008@gmail.com
Yogesh Kumar Pandey
5 Department of Kayachikitsa, Ch. Brahmapraksh Ayurveda Charak Sansthan, Khera Dabar, Najafgarh, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dryogeshpandey@gmail.com
Riju Agarwal
6 Dept. of Shalakya Tantra, Ch. Brahmapraksh Ayurveda Charak Sansthan, Khera Dabar, Najafgarh, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rijuagarwal@gmail.com
Rakesh Rana
7 CCRAS, Ministry of AYUSH, New Delhi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rkrana2000@gmail.com
Arunabh Tripathi
3 Central Council for Research in Ayurvedic Sciences, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ashoka07bhu@yahoo.in
Bhagwan Sahay Sharma
3 Central Council for Research in Ayurvedic Sciences, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bssccras@gmail.com
BCS Rao
3 Central Council for Research in Ayurvedic Sciences, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bhogavalli49@gmail.com
Bharti Gupta
2 Central Ayurveda Research Institute, CCRAS, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: drbharti2@gmail.com
Narayanam Srikanth
3 Central Council for Research in Ayurvedic Sciences, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: srikanthccras@gmail.com
Kartar Singh Dhiman
3 Central Council for Research in Ayurvedic Sciences, New Delhi;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dg-ccras@nic.in
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background: Coronavirus disease 2019 (Covid19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARSCoV2). For persons who are at high risk of exposure, the standard of care is personal protection from getting infected. Whether Ayurvedic rasayana drug like Chyawanprash can prevent symptomatic infection in frontline health care workers is unknown. Objective: To evaluate the effect of the combination of Chyawanprash and Standard Preventive Regimen compared to the use of Standard Preventive Regimen alone on the proportion of RT-PCR confirmed COVID 19 infections among frontline healthcare workers (HCWs). Methods: An open label randomized controlled trial was conducted in the HCWs between 25 to 60 years age currently working in an environment with chance of direct exposure to COVID 19 cases. The interventions to be compared in this trial were Standard Preventive Regimen as per institutional guidelines and based on their roles (Group I) and Ayurvedic Intervention viz., Chyawanprash 12 g twice for 30 days from day of randomization plus Standard Preventive Regimen (Group II). The incidence of RT PCR confirmed COVID19 cases in both groups, was the primary outcome measure. Evaluation of the safety of the study drug (by any statistically significant change in various biochemical and hematological parameters and occurrence of any adverse drug reactions); incidence of any other infective diseases (bacterial / viral / fungal / etc.) like upper respiratory tract illness during the study period and any change in the immunoglobulins like IgG, IgM and IgE and inflammatory markers like TNF alpha, IL6 and IL10 were the secondary outcome measures. Results: Out of 193 participants who completed the study, no participant in both groups was COVID 19 positive at the end of one month. In post intervention follow up, 4 subjects in Group I and 2 subjects in Group II were COVID 19 positive. No adverse drug reaction or any serious adverse event was reported during the study. No clinically significant change in the safety parameters was observed before and after the study. Statistically significant rise in Serum IgG level was seen in Group II but other inflammatory and immune markers did not show statistically significant difference. Conclusion: Chyawanprash was well tolerated by all the participants in the intervention group but to prove its adaptogenic effect and efficacy as an add-on to the standard care in preventing the occurrence of COVID 19, clinical trial for longer duration with larger sample size is needed. Trial registration: Clinical Trials Registry of India vide CTRI/2020/05/025275 dated 20/05/2020 Date of IEC approval: 19.5.2020 Keywords: Adaptogen, Ayurveda, Health personnel, Prophylaxis, Rasayana, SARS CoV 2

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

CTRI/2020/05/025275

Funding Statement

Central Council of Research in Ayurveda Sciences, Ministry of AYUSH, Government of India, New Delhi

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Ethics Committee at Ch. Brahmaprakash Ayurveda Charak Sansthan, Khera Dabar, New Delhi had approved the study on 19th May 2020

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • To add name of one author which was skipped by mistake.

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 23, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Chyawanprash for the prevention of COVID-19 infection among healthcare workers: A Randomized Controlled Trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Chyawanprash for the prevention of COVID-19 infection among healthcare workers: A Randomized Controlled Trial
Arun Gupta, Amit Madan, Babita Yadav, Richa Singhal, Pallavi Suresh Mundada, Yogesh Kumar Pandey, Riju Agarwal, Rakesh Rana, Arunabh Tripathi, Bhagwan Sahay Sharma, BCS Rao, Bharti Gupta, Narayanam Srikanth, Kartar Singh Dhiman
medRxiv 2021.02.17.21251899; doi: https://doi.org/10.1101/2021.02.17.21251899
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Chyawanprash for the prevention of COVID-19 infection among healthcare workers: A Randomized Controlled Trial
Arun Gupta, Amit Madan, Babita Yadav, Richa Singhal, Pallavi Suresh Mundada, Yogesh Kumar Pandey, Riju Agarwal, Rakesh Rana, Arunabh Tripathi, Bhagwan Sahay Sharma, BCS Rao, Bharti Gupta, Narayanam Srikanth, Kartar Singh Dhiman
medRxiv 2021.02.17.21251899; doi: https://doi.org/10.1101/2021.02.17.21251899

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (447)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5196)
  • Forensic Medicine (3)
  • Gastroenterology (192)
  • Genetic and Genomic Medicine (746)
  • Geriatric Medicine (76)
  • Health Economics (210)
  • Health Informatics (689)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5788)
  • Intensive Care and Critical Care Medicine (353)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (140)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (37)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (135)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1983)
  • Radiology and Imaging (340)
  • Rehabilitation Medicine and Physical Therapy (154)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)